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Eﬀ ect of a knowledge-based and skills-based programme for 
physicians on risk of sexually transmitted reinfections 
among high-risk patients in China: a cluster randomised trial
Don Operario, Debin Wang, Nickolas D Zaller, Mei-Fen Yang, Kathleen Blaney, Jing Cheng, Qian Hong, Hongbo Zhang, Jing Chai, Gregory Szekeres, 
Jerome Galea, Thomas J Coates
Summary
Background China is experiencing growing epidemics of HIV and sexually transmitted infections (STIs). Programmes 
to train physicians in China on HIV and STI knowledge, diagnosis, treatment, and risk reduction counselling can 
potentially reduce HIV and STI risk among high-risk patients. We aimed to assess a knowledge-based and skills-
based programme for physicians in China to reduce patients’ STI risk.
Methods In this cluster randomised trial, we block randomised counties in two provinces in eastern China to 
intervention or control groups. In the intervention group, physicians from county general hospitals participated in a 
structured HIV and STI training programme and received opportunities to enhance their clinical and counselling 
skills, whereas in the control group, physicians from county hospitals received the training after the intervention 
group completed ﬁ nal assessments. We recruited STI patients from physicians in both groups, treated baseline 
gonorrhoea and chlamydia infections, and assessed 9-month gonorrhoea and chlamydia reinfection as the primary 
outcome. Statistical comparisons between intervention and delayed-control patients used multilevel analyses to 
account for cluster eﬀ ects at county and physician levels. Analysis was by intention to treat. This study is registered 
with ClinicalTrials.gov, NCT00644150.
Findings Between April 1, 2007, and Sept 1, 2008, 51 counties were randomly assigned; 27 to receive immediate 
intervention and 24 to receive delayed intervention. 249 physicians from the 51 county-level hospitals were enrolled, 
121 physicians in the intervention group and 128 in the control group. From these physicians, we enrolled 633 and 
491 patients, respectively, of whom 508 (80%) and 402 (82%) were available for reassessment at 9 months. Intervention 
patients at follow-up had signiﬁ cantly lower odds of combined gonorrhoea or chlamydia reinfection than did control 
patients (58/508 [11%] vs 123/402 [31%]; adjusted odds ratio 0·62 [95% CI 0·46–0·84]).
Interpretation Integrating HIV and STI training into medical education in China could be an eﬀ ective strategy to 
reduce the country’s growing HIV risk and STI epidemics.
Funding US National Institutes of Health.
Copyright © Operario et al. Open Access article distributed under the terms of CC BY-NC-ND.
Introduction
HIV in China has evolved from an epidemic mainly 
associated with contaminated red-cell infusion after blood 
donation and injection drug use to an epidemic 
increasingly characterised by sexual transmission.1–4 
Although early HIV cases in China were geographically 
concentrated, during the previous decade the epidemic has 
spread throughout all of China’s 31 provinces, autonomous 
regions, and municipalities (excluding Hong Kong, 
Macau, and Taiwan). The Chinese Government has 
responded to the growing epidemic with assertive public 
health policies, such as the 2006 AIDS Prevention and 
Control Regulations, which include initiatives to provide 
free antiretroviral treatment and HIV testing, support 
syringe distribution and drug treatment programmes, 
promote condom use, and reduce AIDS stigma.5–8
Implementation of China’s national AIDS policies 
relies on physicians to deliver prevention and treatment 
of HIV and sexually transmitted infections (STIs) in 
routine practice, including HIV testing, symptom 
diagnosis, treatment recommendations, and risk 
reduction counselling.9–11 However, there are serious 
gaps in physicians’ knowledge and skills in diagnosing 
and treating HIV and STIs.12–17 Interventions to increase 
the ability of Chinese physicians to counsel and to treat 
patients at risk of HIV and STIs have shown 
improvements in physicians’ HIV/STI knowledge and 
clinical skills at follow-up.18–20 These studies have not, 
however, been tested using controlled designs or 
corroborated with patient-level outcomes. A recent 
randomised trial done in China showed the eﬃ  cacy of 
an intervention to reduce physicians’ stigmatising 
attitudes and behaviours towards people living 
with HIV,21 suggesting that HIV/AIDS interventions 
targeting physicians can improve interactions 
with patients.
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We assessed a knowledge and skills-based programme 
for physicians in China to reduce patients’ HIV and STI 
risk. Physicians were trained in HIV and STI transmission, 
diagnosis, treatment, and patient-centred risk reduction 
counselling. The programme, entitled Ai Shi Zi (meaning 
“AIDS Plus” in Mandarin) views physicians as important 
agents of change to reduce HIV and STI transmission and 
risk behaviours among high-risk patients in China. The 
training curriculum is based on social learning theory, 
which emphasises interactive learning, modelling of 
behavioural skills, self-eﬃ  cacy, goal setting, and knowledge 
as determinants of behaviour change.22 We conducted the 
intervention in Anhui and Jiangsu, geographically 
contiguous provinces in eastern China. Both provinces 
have expanding HIV and STI epidemics, with unprotected 
sexual behaviour as a primary risk factor of transmission.23–25 
Our primary hypothesis was a reduction in STI reinfection 
(gonorrhoea and chlamydia) among patients of physicians 
who received the intervention compared with patients of 
physicians in a control group who received the intervention 
after a delay. We also hypothesised improvements in 
knowledge about HIV and STI transmission, attitudes, 
satisfaction with physicians, and condom use among 
patients in the intervention group compared with those in 
the control group.
Methods
Study design and participants
In this cluster-randomised trial, counties were assigned 
to intervention or control groups. Cluster randomisation 
was used to account for interaction, and potential 
contamination, among physicians within hospital 
settings. We contacted administrators of county-level 
general hospitals in Anhui and Jiangsu provinces to 
inform them about the study and to solicit their interest 
in allowing hospital physicians to participate. There was 
one general hospital per county. We randomly assigned 
counties to either the intervention group, in which 
groups of county-level general hospital physicians 
received the training immediately, or to the control group 
in which physicians received the training after physicians 
in the intervention counties completed the study; a 
delayed control group was deemed appropriate to ensure 
that all physicians enrolled in the study had access to the 
information provided in the training. The Ethical Review 
Boards of Anhui Medical University and UCLA approved 
the study, and we obtained written informed consent 
from all participants.
To recruit physicians, we enlisted the provincial health 
bureaus to issue a formal invitation to participating 
county general hospitals. The announcement speciﬁ ed 
the purposes of the project, physician eligibility criteria, 
the fact that participation was entirely voluntary, and that 
some counties would receive training immediately and 
that training for other counties would be delayed. 
Hospitals were not paid to participate. County-level 
physicians were eligible if they were employed at a 
county-level general hospital; specialised in STIs, 
obstetrics, gynaecology, or HIV care; had a minimum 
3 years of clinical experience; had ever treated patients 
with HIV or STIs; and were willing to complete the 
intervention training programme. All costs associated 
with transportation and lodging were paid for, but 
participating physicians were not given ﬁ nancial 
compensation for taking part in the intervention.
Research assistants recruited patients from waiting 
rooms of participating physicians. Between three and 
ten patients were recruited from each physician. Patients 
were informed about the study and those who expressed 
interest were asked to provide a urine sample to test for 
gonorrhoea and chlamydia and to return to the county 
hospital in 2 weeks for test results. All patients who 
tested positive received treatment free of charge 
regardless of enrolment, and those expressing continued 
interest were referred to a study intake coordinator. 
Patients were eligible if they tested baseline-positive for 
gonorrhoea or chlamydia, received treatment, were at 
least 18 years old, received patient services from a 
physician who participated in the training programme, 
and were not planning to relocate in the next 9 months.
Patients in the intervention group were recruited after 
their physicians had completed the ﬁ nal 9-month 
training assessment. Patients in the control group were 
recruited and completed their 9-month follow-up before 
their physicians started the training. Based on this 
design, patient group diﬀ erences at 9-months’ follow-up 
would reﬂ ect comparative eﬀ ects between patients of 
physicians who received the training immediately 
(intervention group) versus patients of physicians who 
had not yet received the training (control group).
Randomisation and masking
To minimise uneven distribution of STI prevalence 
between study groups, counties were rank-ordered within 
province by HIV and STI cases and stratiﬁ ed into 
four blocks, and we randomised counties within each 
block to immediate intervention or control. Randomisation 
was conducted by the project data coordinator based in 
Hefei, the capital of Anhui province, with a computer-
generated randomisation sequence. Allocation of county 
to treatment group remained concealed until site 
investigators were ready to implement the training.
Procedures
The Ai Shi Zi curriculum was developed by Chinese and 
international collaborators based on comprehensive 
literature reviews and consultation activities with local 
and national experts, in both the USA and China. The 
consultation meetings included discussions about 
Chinese national guidelines for HIV and STI treatment 
and infectious disease control, behavioural risk reduction 
strategies, and Chinese cultural issues that can aﬀ ect 
communication with patients. The curriculum took into 
consideration the Chinese medical system by 
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incorporating information related to the provincial 
health-care structures (eg, the organisation of local 
Centers for Disease Control and Prevention, county-level 
and township-level hospitals) and national AIDS policies 
such as access to testing and treatment.
The structure of Ai Shi Zi consisted of three major 
components: (1) an initial 1-week group training held in 
Hefei, Anhui Province, followed by (2) return to clinical 
practice for 2 months to implement new knowledge and 
skills, and (3) two additional two-day group “booster” 
training sessions (at about 3 months and 6 months after 
enrolment) held in Hefei. The initial group training 
covered: HIV and STI biology, pathology, and 
epidemiology; host immune response; opportunistic 
infection and syndrome management; antiretroviral 
therapy; STI treatments; behavioural risk reduction 
counselling; and stigma reduction. Training methods 
incorporated lectures, case studies, small group 
discussions, problem-solving exercises, and role plays. 
Patients with AIDS also gave presentations about their 
experiences living with the disease. After the 1-week 
session, participating physicians returned to their 
hospital-based clinic for 2 months to practise what they 
had learned, and were encouraged to maintain a journal 
describing the most diﬃ  cult or instructive cases 
encountered during clinical practice, which they would 
discuss during follow-up intervention sessions. They 
then reconvened in Hefei for a 2-day workshop and 
practice booster session that focused on individual 
presentations and case studies of diﬃ  cult cases described 
in their journals, group problem solving, and feedback. 
Participant physicians returned again to their clinic for 
2 months, maintaining a journal of diﬃ  cult cases, and 
reconvened for a ﬁ nal 2-day workshop and practice 
booster session. Participant physicians completed a so-
called closing ceremony, which acknowledged their 
participation and encouraged the integration of their 
knowledge and skills in clinical practice.
Participating physicians completed survey assessments 
at baseline, immediately before every booster session 
(3 months and 6 months, respectively), and at 9 months’ 
follow-up. Survey assessments included self-report 
measures, previously validated with Chinese physicians,19 
of the following: knowledge of HIV biology, testing, and 
epidemiology (48 items); syndromic management 
(48 items); management of opportunistic infections 
(41 items); antiretroviral treatment (25 items), and 
behavioural risk reduction counselling (36 items).
Patients completed baseline and 9-month assessments. 
Baseline patient assessments included survey measures 
of HIV and STI knowledge (25-point scale with higher 
scores reﬂ ecting greater knowledge), attitudes towards 
people with HIV (12-point scale with higher scores 
reﬂ ecting more positive and less stigmatising attitudes), 
satisfaction with their physician (7-point scale with 
higher scores reﬂ ecting greater satisfaction), and whether 
they had unprotected sex during the past 6 months. 
Patient survey measures were previously validated with 
Figure: Trial proﬁ le
54 counties approached/assessed
51 counties randomised
27 counties allocated to intervention 24 counties allocated to control 
3 declined due to lack of time 
121 physicians enrolled, completed 
  baseline assessment,  and began 
  intervention
121 physicians completed 9-months’ 
  follow up 
633 patients recruited and 
  completed baseline assessment
508 patients completed 9-month 
  follow-up 
125 patients lost to 
  follow-up
128 physicians enrolled 491 patients recruited and 
  completed baseline assessment
128 physicians completed baseline 
  assessment, begin delayed
  intervention
100 physicians completed 9-month 
  follow-up 
28 physicians lost to 
  follow-up
402 patients completed 9-month 
  follow-up 
89 patients lost to 
  follow-up
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patient samples in China.19 At 9 months’ follow-up, 
patients completed identical surveys and provided urine 
samples to retest for gonorrhoea and chlamydia. Urine 
samples were transferred to the central laboratory of 
Anhui Medical University. Biospecimen testing used the 
ligase chain reaction test (Abbott LCx assay; 
Abbott Laboratories, Abbot Park, IL, USA). Those testing 
positive were contacted and oﬀ ered free treatment. A 
random sample of 10% of specimens was retested to 
check reliability.
Outcomes
The primary outcomes were combined STI (gonorrhoea 
and chlamydia) reinfection rate at 9 months’ follow-up and 
improvements in physician HIV/STI knowledge during 
follow-up. Secondary outcomes were patients’ self-reported 
measures of STI knowledge, attitudes toward people with 
HIV, satisfaction with physician, and condom use during 
the past 6 months.
Statistical analysis
The sample size calculation was based on our primary 
hypothesis concerning patient outcomes. From 
preliminary data derived from our Ai Shi Zi pilot study, 
conducted in diﬀ erent Anhui counties from those 
included in this trial,19 we hypothesised that patients in 
the intervention group would have a 30% reduction in 
combined STI reinfection compared with patients in the 
control group. With an estimated interclass correlation 
coeﬃ  cient of 0·01 based on our pilot, this trial required a 
sample size of 480 patients per group to provide power of 
0·80 at a signiﬁ cance of 0·05 to test our primary 
hypothesis. We planned to recruit four patients per 
physician, requiring 120 physicians per group.
To assess whether the intervention led to improvements 
in physicians’ knowledge, we conducted one-way 
repeated measures ANOVAs to assess the number 
of items answered correctly for each physician knowledge 
domain (HIV/AIDS biology, testing, epidemiology; STI 
syndromic management; management of opportunistic 
infections; antiretroviral treatment; risk reduction 
counselling). We expected physicians in both intervention 
and control groups to show improvements at follow-up 
on all ﬁ ve knowledge domains.
Due to the hierarchical structure of the design (patients 
nested within physicians nested within counties), we used 
mixed eﬀ ects multilevel logistic regression models for 
binary outcomes and ordinary least squares regression 
models for continuous outcomes to account for county-
level and physician-level clustering. All regressions also 
adjusted for basic patient sociodemographic characteristics 
(sex, marital status, employment status). We calculated 
variance across county and physician levels according to 
the speciﬁ ed outcomes, and we undertook regression 
diagnostics, including calculating intraclass correlation 
values, to assess goodness of ﬁ t. We undertook regression 
analyses with an intention-to-treat approach and used the 
last observation carried forward technique to account for 
the 20% missing follow-up data on study outcomes. Data 
were analysed with Stata (version 11.1).
This study is registered with ClinicalTrials.gov, 
NCT00644150.
Role of the funding source
The funder had no role in the study design, data collection, 
data analysis, data interpretation, or writing of the report.
Results
Between April 1, 2007, and Sept 1, 2008, we approached 
54 administrators of county-level general hospitals, of 
whom 51 (39 from Anhui province and 12 from Jiangsu 
province) expressed interest; three declined due to lack of 
time. 27 were randomly assigned to the intervention 
group and 24 to control. 249 physicians from the 
51 county-level hospitals were enrolled. Of these, 
121 physicians were in the intervention group, all of 
whom were reassessed at 9 months, and 128 physicians 
Intervention (n=121) Delayed control (n=128)
Domain 1: HIV/STI biology, testing, and epidemiology (48 items)
Baseline 48·7% (23·4; 0·09) 48·4% (23·2; 0·09)
3 months 63·9% (30·7; 0·10) 61·3% (29·4; 0·10)
6 months 71·5% (34·3; 0·11) 74·9% (36·0; 0·11)
9 months 72·9% (35·0; 0·12) 79·5% (38·2; 0·12)
One-way ANOVA F(3,360)=208·5; p=0·01 F(3,299)=527·0; p=0·01
Domain 2: STI syndromic management (48 items)
Baseline 49·4% (23·7; 0·13) 50·2% (24·1; 0·14)
3 months 58·7% (28·2; 0·12) 66·3% (31·8; 0·15)
6 months 67·1% (32·2; 0·16) 79·1% (38·0; 0·17)
9 months 66·6% (32·0; 0·18) 80·5% (38·6; 0·16)
One-way ANOVA F(3,360)=88·8; p=0·01 F(3,299)=515·9; p=0·01
Domain 3: Management of opportunistic infections (41 items)
Baseline 38·1% (15·6; 0·11) 39·1% (16·0; 0·09)
3 months 60·3% (24·7; 0·18) 48·3% (19·8; 0·12)
6 months 64·4% (26·4; 0·16) 57·2% (23·4; 0·15)
9 months 64·3% (26·4; 0·17) 62·8% (25·8; 0·15)
One-way ANOVA F(3,360)=118·8; p=0·01 F(3,299)=231·6; p=0·01
Domain 4: Antiretroviral treatment (25 items)
Baseline 33·6% (8·40; 0·11) 34·8% (8·70; 0·10)
3 months 51·3% (12·8; 0·12) 42·7% (10·7; 0·15)
6 months 53·4% (13·3; 0·15) 48·2% (12·1; 0·17)
9 months 55·1% (13·8; 0·15) 52·2% (13·1; 0·18)
One-way ANOVA F(3,360)=113 00; p=0 01 F(3,299)=81·2; p=0·01
Domain 5: Risk reduction counselling (36 items)
Baseline 42·9% (15·5; 0·15) 40·9% (14·7; 0·14)
3-months 64·3% (23·4; 0·16) 66·1% (23·8; 0·17)
6-months 74·5% (26·8; 0·17) 83·3% (30 0; 0·14)
9-months 76·7% (27·6; 0·17) 90·4% (32·6; 0·09)
One-way ANOVA F(3,360)=469·5; p=0·01 F(3,299)=785·8; p=0·01
Data are % correct (M items correct; SD). STI=sexually transmitted infection.
Table 1: Physician HIV/STI knowledge domains at baseline, 3 months’, 
6 months’, and 9 months’ follow-up by intervention (n=249)
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were in the control group, of whom 100 (78%) were 
reassessed at 9 months (ﬁ gure). No diﬀ erences were 
noted in baseline measures between physicians who 
completed the 9-month assessment versus those who did 
not complete the 9-month assessment.
Table 1 shows descriptive physician scores on the 
ﬁ ve assessed HIV knowledge domains. Baseline 
knowledge scores did not diﬀ er between intervention 
and control groups. As expected, we noted improvements 
in both intervention group and control groups for all 
domains: HIV/STI biology, testing, and epidemiology 
(p=0·01); STI syndromic management (p=0·01); 
management of opportunistic infections (p=0·01); 
antiretroviral treatment (p=0·01); and risk reduction 
counselling (p=0·01; table 1).
1124 patients were recruited from participating 
physicians. Of these, 862 (77%) were men, 1072 (95%) 
were of Han ethnicity, 878 (78%) were from 
Anhui province, 785 (70%) were educated below the high 
school level, 842 (75%) were currently employed, and 
850 (76%) were married. No signiﬁ cant baseline 
diﬀ erences in sociodemographic characteristics were 
noted between the intervention and control patients. Of 
633 patients in the intervention group at baseline, 
508 (80%) were reassessed at 9 months; of 491 patients in 
the control group at baseline, 402 (82%) were reassessed 
at 9 months. No signiﬁ cant sociodemographic diﬀ erences 
were noted between patients who completed versus those 
who did not complete the 9-month assessment.
At baseline, 910 (81%) of 1124 patients tested positive 
for gonorrhoea or chlamydia (or both): 508 (77%) of 
663 in the intervention group and 402 (82%) of 491 in the 
control group. 838 (75%) of 1124 patients tested positive 
for gonorrhoea (475 [75%] of 633 patients in the 
intervention group vs 363 (74%) of 491 patients in the 
control group) and 598 (53%) of 1124 tested positive for 
chlamydia (356 [56%] of 633 patents in the intervention 
group vs 242 [49%] of 491 patients in the control group. 
Baseline group diﬀ erences in patient gonorrhoea and 
chlamydia were not statistically signiﬁ cant; all patients 
who were infected with gonorrhoea and chlamydia at 
baseline were treated. At 9-month follow-up, after 
adjustment for county and physician levels, patients in 
the intervention group had signiﬁ cantly lower odds of 
combined STI (gonorrhoea or chlamydia) and 
gonorrhoea reinfection only at 9 months’ follow-up 
(table 2). Group diﬀ erences in 9-month chlamydia 
reinfection were not statistically signiﬁ cant (table 2).
Table 3 shows the eﬀ ects of the intervention on patients’ 
follow-up levels of unprotected sex during the past 
6 months, HIV knowledge, attitudes towards people 
living with HIV, and physician communication. In 
multilevel regression, which adjusted for county and 
physician levels, we noted that patients in the intervention 
Combined STI Gonorrhoea Chlamydia
n/N (%) AOR (95% CI) n/N (%) AOR (95% CI) n/N (%) AOR (95% CI)
Intervention 58/508 (11%) 0·62 (0·46–0·84) 44/508 (9%) 0·68 (0·49–0·60) 39/508 (8%) 0·79 (0·56–1·12)
Control 123/402 (31%) 1·00 92/402 (23%) 1·00 75/402 (19%) 1·00
 Multilevel models adjusted for county and physician levels. STI=sexually transmitted infection.
 Table 2: Eﬀ ects of intervention on STI (gonorrhoea or chlamydia) reinfection at 9 months’ follow-up 
Unprotected sex, past 
6 months*
HIV knowledge Attitudes towards people 
with HIV
Physician communication
Study group
Intervention 0·10 (0·12 to 0·42) 2·13 (1·52 to 2·73) 1·51 (0·97 to 2·05) 0·22 (0·15 to 0·30)
Delayed control 1·00 1·00 1·00 1·00
Sex
Male 1·32 (0·77 to 2·25) 0·07 (–0·46 to 0·59) 0·25 (–0·24 to 0·75) 0·03 (–0·01 to 0·07)
Female 1·00 1·00 1·00 1·00
Marital status
Never married 1·00 1·00 1·00 1·00
Married 2·23 (1·36 to 3·65) –1·04 (–1·58 to –0·50) –0·79 (–1·31 to –0·28) 0·001 (–0·04 to 0·04)
Divorced or separated 0·48 (0·20 to 1·19) –1·50 (–2·72 to –0·29) –2·09 (–3·24 to –0·94) –0·03 (–0·12 to 0·07)
Widowed ·· –3·45 (–6·23 to –0·67) –0·14 (–2·78 to 2·48) –0·07 (–0·25 to 0·12)
Employment
Yes 0·85 (0·51 to 1·41) 0·64 (0·13 to 1·14) –0·14 (–0·62 to 0·34) 0·01 (–0·02 to 0·05)
No 1·00 1·00 1·00 1·00
Data are *AOR (95% CI) or adjusted β (95% CI). Multilevel models adjusted for county and physician levels. AOR=adjusted odds ratio. 
Table 3: Intervention eﬀ ects on patient unprotected sex, HIV knowledge, attitudes towards people with HIV, and communication with physician
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group at follow-up were signiﬁ cantly less likely to report 
unprotected sex during the past 6 months than were 
control patients (426/508 vs 382/402; table 3). Intervention 
patients also had signiﬁ cantly higher HIV/STI knowledge 
scores (M=16·8 [SD 3·10]) compared with control 
patients (M=14·91 [SD 3·19]; table 3); and higher 
physician satisfaction (M=2·43 [SD 0·22]) compared 
with control patients (M=2·29 [SD 0·54]; table 3). 
Although not statistically signiﬁ cant, attitudes towards 
people living with HIV tended to be moderately more 
positive among intervention patients (M=8·50 [SD 3·43]) 
compared with control patients (M=7·15 [SD 3·10]; 
table 3). In these multilevel mixed-eﬀ ects logistic models, 
which included county and physician levels, county level 
accounted for 19–26% of the total variance and physician 
level accounted for 17–20% of the total variance, 
depending on the choice of outcome. On the basis of 
these regression diagnostics and the ICC values, these 
models show reasonable goodness of ﬁ t.
No harms were reported during the conduct of this trial.
Discussion
Training physicians in China on HIV and STI knowledge, 
treatment, and risk reduction counselling, and 
motivating them to integrate prevention and treatment 
into routine care resulted in lower reinfection with 
gonorrhoea and chlamydia in patients at 9 months 
(panel). Patients of physicians who received the training 
had 38% lower odds of combined gonorrhoea and 
chlamydia reinfection and 32% lower odds of gonorrhoea 
reinfection alone compared with patients of physicians 
in the delayed control. The protective intervention eﬀ ect 
trend for chlamydia reinfection alone was not statistically 
signiﬁ cant, suggesting either that the non-signiﬁ cant 
eﬀ ect was due to chance or that our sample size was 
inadequate to determine a deﬁ nitive beneﬁ t . We suspect 
the latter, in view of the signiﬁ cant eﬀ ect of the 
intervention on the combined STI and gonorrhoea-alone 
endpoints. Eﬀ ects on HIV incidence were not assessed 
owing to the prohibitive sample size needed to determine 
such an eﬀ ect. Patients of physicians who received the 
training also reported 78% lower odds of unprotected sex 
during the past 6 months as well as signiﬁ cantly 
improved HIV and STI knowledge, attitudes towards 
people living with HIV, and satisfaction with physicians. 
To our knowledge, this is the ﬁ rst study in China that 
uses a randomised trial to assess the eﬀ ects of physician 
HIV and STI training on indicators of patient-level 
biological, behavioural, and sociocognitive risk.
There were several unique features of the Ai Shi Zi 
programme that could have contributed to the observed 
eﬀ ects. First, the programme recognised and included 
up-to-date information about national AIDS policies and 
local health infrastructure, including availability and 
guidelines for HIV medications and STI treatment, 
which can aﬀ ect service provision for patients. Second, 
the programme included culturally sensitive information 
about risk reduction counselling, stigma towards people 
living with HIV, and traditional norms and beliefs that 
can inﬂ uence physicians’ interactions with patients. 
Presentations by local patients with AIDS about their 
perspectives on health care, stigma, and living with the 
disease could have been particularly relevant to this 
programme. Third, the programme incorporated several 
strategies to train physicians and model new skills. For 
example, interactive learning strategies complemented 
didactic lectures, which tend to be the dominant mode of 
instruction in China. Fourth, booster sessions provided 
additional opportunities for problem solving, feedback, 
and professional support.
Findings from the Ai Shi Zi project are consistent with 
studies done in the USA showing the role of physician 
training to reduce HIV transmission risk among patient 
populations. For example, a randomised trial of a brief 
4-h training for medical providers on behavioural risk 
counselling with HIV-positive patients noted signiﬁ cantly 
increased provider-patient discussions of safer sex and 
reduced number of sex partners among patients 
compared with patients of physicians who were not 
trained.26 Similar studies have shown the eﬀ ects of 
provider-initiated safer sex counselling to HIV-positive or 
at-risk patients on behavioural risk reduction outcomes 
compared with patients in control groups without 
provider-initiated counselling.27,28 These studies align 
with recommendations by the US CDC for the integration 
of routine HIV and STI assessment and risk reduction 
counselling in clinical settings serving HIV-infected 
populations.29 Based on ﬁ ndings from Ai Shi Zi, 
integration of HIV and STI prevention into routine care 
for risk populations in China could be warranted.
Due to stigma, traditional cultural beliefs, and 
inadequate institutional support, physicians in China 
might experience challenges to HIV and STI-related 
service provision.30 Results from Ai Shi Zi, and a related 
intervention shown to reduce HIV stigma in Chinese 
physicians entitled “White Coat, Warm Heart”,21 indicate 
that these challenges can be overcome by programmatic 
eﬀ orts to engage physicians, provide educational 
training and support, and shift norms around services 
for HIV-risk patient populations. Questions remain, 
however, regarding the speciﬁ c strategies needed to 
broadly disseminate and implement these programmes. 
“White Coat, Warm Heart” involved four group training 
sessions over a 1-month period and three additional 
booster sessions, whereas Ai Shi Zi involved a 1-week 
group training and two additional booster sessions. 
Speciﬁ c training components that contributed to 
intervention eﬀ ects have not been identiﬁ ed in either 
study. Because of programme length and complexity, 
institutional support, and training resources will be 
needed to scale up these training programmes. In 
addition to eﬀ orts to improve physician training, public 
health strategies such as partner tracing, partner 
notiﬁ cation, and partner treatment might enhance 
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identiﬁ cation and prevention of HIV and STI cases in 
China, and warrant further study.
Limitations to this research must be considered. The 
study used a brief 9-month follow-up, and we cannot 
comment on longer-term eﬀ ects. There might be 
limitations in representativeness and generalisability of 
study ﬁ ndings owing to selection biases and non-
monetary incentives (eg, paid trip to Hefei for 
professional training) among physicians who agreed to 
participate; we also do not have information about the 
size of the full sampling frame of physicians, and cannot 
determine the proportion of physicians represented in 
this study. We undertook the training in county hospitals 
that allowed for recruitment and physician participation; 
ﬁ ndings might not generalise to hospital settings where 
physicians do not have institutional support to 
participate. Patients were recruited from waiting areas of 
participating physicians, and these patients might not 
represent those who do not seek health services. Patient 
attrition levels were high and study ﬁ ndings might be 
less reliable due to the amount of missing data (20%); 
challenges in patient retention might possibly reﬂ ect 
high levels of internal migration. We did not observe or 
collect data about the clinical encounters between trained 
physicians and patients, and so we cannot specify 
the exact physician-level factors that inﬂ uenced 
improvements in patient outcomes. We did not collect 
detailed information about physician demographic 
backgrounds and thus are unable to examine physician 
background characteristics that might moderate 
the intervention eﬀ ects. There might have been 
contamination such that control participants later in the 
trial might have been exposed to intervention content. 
We sampled only 10% of biospecimens for reliability. 
Biological results might not be generalisable to other 
STIs, including HIV or syphilis.
In summary, this research provides empirical support 
for the eﬃ  cacy of physician training on HIV and STI 
knowledge, treatment, and risk reduction counselling as 
a strategy to prevent HIV risk and STI reinfection in 
China. Future analyses based on this trial should provide 
greater understanding of the behavioural mechanisms, 
psychosocial factors, and patient characteristics that 
contributed to the intervention eﬀ ects. For example, the 
intervention is likely to have led to improved patient-
physician communication, higher levels of patient self-
eﬃ  cacy, and greater levels of patient awareness about 
HIV risk. Intervention eﬀ ect moderators will also be 
examined, including patient characteristics such as sex, 
marital status, and socioeconomic status, to identify 
whether the intervention has greater eﬀ ect on speciﬁ c 
subgroups. A report on the implementation processes, 
content, and curricula is also planned.
As HIV and STI epidemics in China continue to 
expand, strategic interventions are needed to reach those 
populations at highest risk.31 Improvement in HIV and 
STI expertise in the next generation of health providers 
in China is one such strategy, yet requires institutional 
and political commitment, in terms of human resources, 
educational investments, and motivation for engagement 
in training. In view of the sheer size and reach of the 
HIV and STI epidemics in China, such investments are 
likely to have considerable public health and population-
level beneﬁ ts.
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